Raymond James cuts CDW stock price target on operating leverage concerns

Raymond James cut its price target on CDW to $150 from $190 while keeping a Strong Buy rating, citing limited operating leverage, low-single-digit EBIT growth, and valuation multiple compression. CDW's first quarter showed EPS of $2.28 versus $2.26 expected and revenue of $5.7 billion versus estimates by $240 million, but margins remain pressured at 21.73% gross margin. The stock trades near $107, about 10x earnings, and the firm said a return to double-digit EPS growth likely requires clearer operating improvement.

Analysis

The market is treating CDW like a low-quality cyclical, but the bigger issue is not top-line demand — it is conversion of gross profit into EBIT. That makes this less of a “software vs. hardware” debate and more a question of whether management can re-rate the multiple by proving cost discipline in a business where every incremental point of operating leverage matters. If the new initiative only delivers incremental savings, the stock can still work, but the upside is capped unless the savings show up quickly in margin inflection rather than just slower decline.

The second-order read-through is to peers with similar reseller/distribution economics: the market will likely reward names that can show cleaner contribution margins and punish anyone still carrying bloated SG&A. That favors vendors with tighter inventory turns and more mix shift toward higher-margin recurring services, while legacy IT distributors remain vulnerable to multiple compression if enterprise spending stays constructive but not strong enough to expand margins. In other words, a soft-demand backdrop is not the real problem; a “good enough” demand backdrop that fails to create operating leverage is worse because it prolongs de-rating.

Catalyst timing matters. Over the next 1-2 quarters, the stock likely trades on evidence of margin stabilization, not EPS beats alone, because the market has already learned to discount revenue surprises from this name. The key tail risk is that cost savings get competed away through pricing or offset by inventory/supply-chain friction, which would keep the name trapped at a low-teens or sub-10x multiple. A clean move back toward a premium multiple requires at least several quarters of sequential EBIT improvement, not a single quarter of better execution.

Contrarian angle: the selloff may be overdone if investors are extrapolating one weak operating print into a permanent structural impairment. If management can show even low-single-digit EBIT growth from self-help alone, the valuation floor should rise before revenue growth improves, creating a classic multiple-expansion setup. The asymmetry is attractive because downside from here is more about time decay than business deterioration, while upside can compound quickly if the market decides the margin reset is real.

Key Decisions for Investors

• Go long CDW on a 1-3 month horizon only on confirmation of sequential EBIT margin improvement; target a re-rate toward 11-12x earnings if management proves savings are flowing through, with downside limited to the recent low if execution disappoints.
• Use a call spread in CDW rather than outright equity for the next earnings cycle; the setup is a timing trade on margin stabilization, so defined risk is preferable if the market remains skeptical through another quarter.
• Pair trade: long CDW / short a weaker IT-distribution or hardware-reseller peer with inferior operating leverage over the next 2 quarters; the spread should widen if the market rewards self-help and punishes margin laggards.
• If CDW fails to show sequential EBIT improvement by the next report, exit longs and rotate into higher-quality enterprise IT names with recurring revenue exposure; the risk/reward shifts sharply if the multiple remains anchored below 10x.
• For opportunistic traders, buy CDW only after a post-earnings flush that is not accompanied by worse guidance; that creates a better entry point for a 6-12 month mean reversion trade as the market prices in the cost-savings initiative.